Clinical Trial Update: Cardiac Sarcoidosis Response To Steroids Trial [Phase 4]

View source ↗

Summary

The Phase 4 clinical trial evaluating response to steroids in cardiac sarcoidosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Sarcoidosis
• Sarcoidosis

Drugs mentioned

• steroids

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Cardiac Sarcoidosis, Sarcoidosis | Phase 4 | Status: WITHDRAWN